Plain-English translation of NCT06314607 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large research study that aims to understand the genetic makeup of brain tumors and other brain lesions. Researchers want to collect tissue samples, blood samples, and medical information from thousands of patients over 10 years to discover which genetic changes affect how tumors behave and respond to treatment. This knowledge could help doctors diagnose brain tumors more accurately and develop better treatments in the future.
Brain tumors like glioblastoma are currently difficult to treat and often resist standard therapies. By studying the genetic patterns in these tumors, researchers hope to find new ways to classify them, predict how individual tumors will respond to treatment, and eventually develop new therapies that work better for patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you may be asked to donate tissue samples (often collected during surgery you're already having), blood samples, and allow researchers to access your medical records and test results. Depending on whether you're being followed at Pitié Salpêtrière Hospital, you might be contacted during a routine visit or hospitalization to enroll, or researchers may reach out if you've been treated elsewhere. The study is ongoing for 10 years, so participation could involve periodic contact, but most involvement happens during your regular medical appointments.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
France